Genomma Lab Internacional Reports Fourth Quarter & Full Year 2018 Results

Wednesday, February 27, 2019 Clinical Trials News
Email Print This Page Comment bookmark
Font : A-A+

Q4-2018

 % Sales

Q4-2017

% Sales

Var. %

Net Sales

3,136.4

100.0%

2,885.2

100.0%

+8.7%

Gross Profit

2,012.9

64.2%

1,798.0

62.3%

+11.9%

Operating Income

550.6

17.6%

595.9

20.7%

(7.6)%

EBITDA(2)

579.3

18.5%

613.2

21.3%

(5.5)%

Net Income(3) 

327.0

10.4%

338.6

11.7%

(3.4)%

(2) EBITDA is defined as operating income before depreciation and amortization.

(3) Net Income of Majority Shareholders for 2017.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store